Fig. 5From: Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control studyThe ratio of CD8-/CD8+ T-cells among (a) lung cancer patients and controls, (b) according to cancer disease stages, at baseline (T0), 1Â month (T1), 3Â months (T3), and 6Â months (T6)Back to article page